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Coxiella burnetii, which causes Q fever, is a highly infectious agent that is widespread around the world.  
During the last decades, the number of cases reported in Bulgaria varied from year to year. The present study 
aimed to determine the frequency of C. burnetii infection using ELISA and conventional PCR among freelance 
veterinarians and cattle farm workers in Gabrovo province, Bulgaria. In the period April 2020 to June, 2021 a 
total of 154 blood samples of target group was tested in the National Reference Laboratory of Cell cultures, 
rickettsia and oncogenic viruses (NRL CCROV) at NCIPD - Sofia. Diagnosis of C. burnetii was performed by 
indirect enzyme-linked immunosorbent assay ELISA (anti-Coxiella burnetii ph. II IgG/IgM) and by end-point 
PCR technique (to detect the sodB gene region of C. burnetii). By indirect ELISA assay of the tested 154 
clinical samples, anti-C. burnetii positive ph. II IgM antibodies were registered in 37% of samples. A relatively 
high percentage are affected in the active age between 50-60 years old. Anti-C. burnetii positive ph. II IgG 
antibodies were proven at 50% of tested samples.  
------------------------------------------------------------------------ 
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A positive PCR signal for C. burnetii DNA was obtained at 37/154 (20% of samples) and follows the above 
reported trend of acute infection of active age patients. Around 10% of tested samples were positive for three C. 
burnetii laboratory markers. We conclude that Q fever is endemic in Bulgaria. More research is necessary in 
different Bulgarian regions to set the human risk groups, to diagnose acute and chronic Q fever and to determine 
the economic impact of Q fever in the cattle industry. In the NRL CCROV was developed diagnostic scheme 
including complex methods to improve early laboratory diagnosis of C. burnetii, allowing taking proper 
treatment of suspected with Q fever patients. 
Keywords: Coxiella burnetii; seroepidemiology; end-point PCR; freelance veterinarians and cattle farm 
workers; Gabrovo regions; Bulgaria. 
1. Introduction  
Zoonoses are constantly growing group of infections, which have emerged and reemerged as the foremost 
global security challenge throughout the world. They increasingly spread among human population like 
epizootic outbreaks and epidemics, with serious social, environmental and economic impact [1, 2]. Rapidly 
advancing climate changes, caused by global warming, increased trade in live animals and globalizing world, 
enhance existing natural and anthropurgic foci of several diseases with zoonotic potential [3, 4].  One of the top 
global priority zoonosis is Q fever, caused by intracellular gram-negative bacterium Coxiella burnetii, 
established on all continents, with the exception of New Zealand [5]. However, this infectious is still neglected 
and under-reported in most of countries, because the clinical signs in both acute and chronic forms of Q fever 
are nonspecific, the incubation period is relatively long, the levels of C. burnetii in clinical samples is too low, 
absent specific laboratory conformation and appropriate treatment protocols [6, 7]. Coxiella burnetii is included 
in category "B" list of potential biological weapons [8]. The host range susceptible to Q infection is too large 
and includes a variety of wild and domestic animals, birds and amphibians, and the ability of ticks to stored and 
transmitted as vectors Q infectious agent are associated with the formation of natural outbreaks [9, 10]. Infected 
animals, even if asymptomatic, can spread this bacterium to the environment through body fluids such as milk, 
urine, stool, cervical mucus, and fluids at the time of delivery or during miscarriage [11]. Transmission to 
humans is most frequently due to inhalation of aerosolized bacteria that are spread in the environment by 
infected animals and rarely alimentary [12]. Additionally, factors such as a large number of infected animals, 
farms located close to populated areas, and lack of epidemiological surveillance increase the incidence of 
infection [12]. Clinical manifestation of acute Q fever in humans can be asymptomatic (50%), but there can also 
be signs including atypical pneumonia, granulomatous hepatitis, meningioencephalitis and endocarditis [13, 14]. 
Infectious endocarditis is the most common form of chronic Q fever infection and patients with valvular and 
vascular lesions are at high-risk and is fatal if untreated [15, 16]. Because the clinical presentation is similar to 
that of other diseases, Q fever often remains underdiagnosed [12, 13]. Laboratory diagnosis of acute Q fever is 
ideally based on a combination of PCR and serology in blood and serum samples [16, 17]. IgM Phase II is still 
detectable 12 months after transmission of C. burnetii in 62-83% of the serum samples [18]. Seroconversion or a 
4-fold increase in the IgG phase II titer is used to confirm the diagnosis of acute Q fever [19]. PCR has been 
shown to be positive for almost all early acute Q fever patients that have not yet an antibody response and in 
almost all of those that have peak an IgM phase II antibody response [20]. Concerning Q fever in humans, 
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current epidemiological studies indicate that this zoonosis should be considered a public health problem in many 
countries, including Netherlands, France, the United Kingdom, Italy, Spain, Germany, Israel and Greece, as well 
as in many countries where Q fever is prevalent but unrecognized because of poor surveillance of the disease 
[21 – 27]. In Bulgaria, Q fever in humans was first recognized by Mitov and his colleagues in 1949 [28]. For 
more than 60 years, numerous sporadic cases and small and large epidemics, involving tens to hundreds of 
persons, occurred in different regions of the country [29, 30].  Based on previous studies 2017, in Gabrovo 
region, the presence of C. burnetii has been confirmed among the livestock and humans from several villages of 
the area [31]. The present study aimed to determine the frequency of C. burnetii infection using ELISA and 
conventional PCR among freelance veterinarians and cattle farm workers in Gabrovo province, Bulgaria.  
2. Materials and Methods 
In this study, we assessed the seroprevalence rate of Coxiella burnetii and to confirm with molecular technique 
in blood samples of veterinarians, who practice hourly in various livestock farms in Gabrovo region, as well as 
and cattle farm workers of the region from April, 2020 till June, 2021.  
2.1. Area of study and population 
Gabrovo province is a small province lying at the geographical centre of Bulgaria on the territory 2026,005 km
2
. 
Gabrovo district is divided territorially and administratively into 4 municipalities, bearing the names of their 
main cities and included 344 villages. In 2009 the total population of the area is 130,001. The leading areas of 
animal husbandry in the province are cattle and sheep breeding (Fig. 1). 
 
Figure 1: Gabrovo province is located in the geographical centre of Bulgaria in the north part of Stara Planina 
 American Scientific Research Journal for Engineering, Technology, and Sciences (ASRJETS) (2021) Volume 81, No  1, pp 92-99 
95 
 
2.2. Patient characteristics 
The study was conducted at the National Centre of Infectious and Parasitic Diseases – Sofia (Bulgaria) in the 
National Reference Laboratory of Cell cultures, rickettsia and oncogenic viruses (NRL CCROV). The study 
group was 154 patients (103 men and 51 women). Details of their clinical history were recorded on admission. 
Cases and positive samples were described by region, age group, sex and laboratory test. All the patients gave 
their informed consent before being included in the study. In generally, study patients were of Bulgarian 
nationality and lived in Gabrovo province.  
2.3. Coxiella burnetii serological studies 
Blood samples were taken on admission by venipuncture from each patient and tested for anti-C. burnetii IgM 
and IgG phase II antibodies by indirect enzyme-linked immunosorbent assay ELISA (Euroimmun, Lűbeck, 
Germany). Blood was centrifuged at 4000g for 10 min, serum was aliquoted and stored for a maximum of 
3 days at 4°C before use in the Q fever-ELISA and then harvested and frozen at -80
o
C until further analysis. 
According to data provided by the manufacturer anti-C. burnetii IgM/IgG phase II ELISA tests have a 
sensitivity respectively of 91.7% / 97.1% and a specificity of 90% / 91.8%. The ELISA tests were performed 
according to the manufacturer’s instructions. Both tests were a semi-quantitative, in which results are expressed 
as a ratio of extinction value of the control or patient sample over extinction value of the calibrator (ratio = 
extinction of the control or patient sample/extinction of the calibrator). In Euroimmun test ratio ≥ 1.1 was taken 
as positive. Samples were negative if the absorbance value was < 0.8.  
2.4. Molecular detection of Coxiella burnetii 
Whole blood samples were taken on admission by venipuncture from each patient and collected into in 
ethylenediaminetetraacetic acid (EDTA Becton, Dickinson and Company, USA) blood tubes. The samples were 
handled under sterile conditions to avoid cross-contamination. Following collection, samples were transported 
on ice to the NRL CCROV, where whole blood samples were centrifuged, aliquots for DNA extraction, and rest 
plasma stored at -80°C for further analysis. DNA from blood samples were extracted with the QIAamp DNA 
Blood Mini Kit (Qiagen Inc., Valencia, CA, USA) according to the manufacturer’s instructions. The genomic 
DNA of each sample was stored at -20°C under sterile conditions. The extracted DNA was subjected to an end-
point PCR assay.  To the reaction mixture, prepared at a volume of 22.5 µl in 0.2-ml test tubes for each sample, 
was added 2.5 µl of the DNA extract, and amplification was performed as described by Stein A, Raoult D. 
(1992) [32]. For the sodB gene, using the specific primers CB1 and CB2, which product is 257 bp in length and 
is specific to the DNA of C. burnetii CB1 (5’ ACT CAA CGC ACT GGA ACG GC 3’) and CB2 (5’ TAG CTG 
AAG CCA ATT CGC C 3’) primers were used. Following amplification, electrophoresis was performed in 
1.5%agarose gels, and the results were imaged 
2.5. Statistical analysis 
The tests included frequency calculation, frequency percentage, and chi-square test. Variables with control 
distribution are presented as mean and standard deviation (SD).  
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3. Results and Discussion 
 In the period April, 2020 till June, 2021 154 study patients, 67% were man and 33% women. The tested 
patients are from endemic for Q fever Bulgarian region (Gabrovo) in which were report small epidemic 
outbreak in 2017 [31]. Age range of the participants was 18 - 70 years. By indirect ELISA assay of the tested 
clinical samples, anti-C. burnetii positive ph. II IgM antibodies were registered at 57/154 (37% of samples). A 
relatively high percentage are affected in the active age between 50-60 years old, with a predominance of men 
(about 70%). Anti-C. burnetii positive ph. II IgG antibodies were proven at 77/154 (50%). A positive PCR 
signal for C. burnetii DNA was obtained at 37/154 (20%) and follows the above reported trend of acute 
infection of active age patients. Around 10% of tested samples were positive for three C. burnetii laboratory 
markers (Figure 2).  The presence of anti-Coxiella IgG ph. II antibodies was positively associated with 
increasing age: very few reactive antibodies were found in youths under 20 years of age, while they positivity 
increased from 15% in 21–30 year olds to 29% in adults over 30 years of age (Fig. 2). Patients in the age group 
50-60 years have a typical acute Q fever clinical manifestation (fever of unknown origin, headache, myalgia) 
with the highest frequency. PCR has been shown to be positive for almost all early acute Q fever patients that 
have not yet an antibody response and this method can be used as a first choice for diagnosis during an epidemic 
outbreak. A history of contact with animal birth products was significantly related to C. burnetii seropositivity. 
 
Figure 2: Distribution of proven positive patient samples for C. burnetii with a combination of diagnostic 
markers in percentages by age groups (n = 154) 
4. Conclusions 
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research is necessary in different areas of Bulgaria to set the human risk groups, to diagnose acute and chronic Q 
fever and to determine the economic impact of Q fever in the cattle industry. Concerning acute Q fever, we 
propose the physicians in Bulgaria to request testing for acute Q fever in cases of atypical pneumonia in risk 
groups like cattle farm workers, veterinaries and slaughterhouse workers. Although C. burnetii occurs in most 
parts of the world, the prevalence of infections in humans is often underestimated because definitive testing is 
not carried out and signs are generally subclinical or confused with more common diseases [33, 34]. Diagnosis 
is of key importance to the control, monitoring and adequate antibiotic treatment of Q fever. The results of this 
study indicated that indirect ELISA assay and PCR were a sensitive method for proving of acute C. burnetii 
infection. Our findings also call for further investigation into the clinical relevance of chronic Q fever in 
different regions in Bulgaria. Knowledge about chronic Q fever is limited, but the studies that have been 
conducted showed that about 5% of the patients who got infected with C. burnetii would develop chronic Q 
fever. Additional serological and clinical monitoring is recommended for the patients detected in this study to 
determine if they have high anti-C. burnetii IgG phase I antibody titers. In the NRL CCROV was developed 
diagnostic scheme including complex methods to improve early laboratory diagnosis of C. burnetii, allowing 
taking proper treatment of suspected with Q fever patients. 
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